Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,652,716
  • Shares Outstanding, K 129,832
  • Annual Sales, $ 454,460 K
  • Annual Income, $ -175,150 K
  • 60-Month Beta 1.37
  • Price/Sales 22.64
  • Price/Cash Flow N/A
  • Price/Book 13.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.37
  • Number of Estimates 6
  • High Estimate -0.32
  • Low Estimate -0.40
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +15.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.35 +7.61%
on 11/14/19
97.08 -15.37%
on 10/21/19
-14.31 (-14.83%)
since 10/18/19
3-Month
76.35 +7.61%
on 11/14/19
123.31 -33.37%
on 08/29/19
-37.66 (-31.43%)
since 08/16/19
52-Week
53.06 +54.84%
on 12/24/18
123.99 -33.74%
on 07/30/19
+10.78 (+15.10%)
since 11/16/18

Most Recent Stories

More News
Medtronic (MDT) to Report Q2 Earnings: What's in Store?

In the fiscal second quarter, Medtronic (MDT) is expected to have registered strong growth in its ICD and CRT product lines.

MDT : 111.25 (-0.72%)
EXAS : 82.16 (+0.13%)
ACAD : 45.07 (-2.23%)
JAZZ : 138.62 (-0.01%)
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth

EXAS : 82.16 (+0.13%)
GHDX : 63.44 (-0.69%)
Exact Sciences Presents Data On Blood-Based Test For Detection Of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation

(NASDAQ: EXAS) - A new study of 443 patients by Exact Sciences Corp. and its collaborators demonstrated 80% sensitivity at 90% specificity with a novel combination of six blood-based biomarkers for the...

EXAS : 82.16 (+0.13%)
Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences

Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today.

EXAS : 82.16 (+0.13%)
GHDX : 63.44 (-0.69%)
SmarTrend Watching for Potential Rebound in Shares of Exact Sciences After 12.69% Loss

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $82.01 to a high of $84.58. Yesterday, the shares fell 12.7%, which took the trading range below the 3-day low of $83.26...

EXAS : 82.16 (+0.13%)
Shenandoah Telecommunications Set to Join S&P SmallCap 600

Shenandoah Telecommunications Co. (NASD: SHEN) will replace Genomic Health Inc. (NASD: GHDX) in the S&P SmallCap 600 effective prior to the open of trading on Friday, November 8. Exact Sciences Corp. (NASD:EXAS)...

SHEN : 36.05 (-1.07%)
GHDX : 63.44 (-0.69%)
EXAS : 82.16 (+0.13%)
SPGI : 264.08 (+0.45%)
Exact Sciences to participate in November investor conferences

Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast.

EXAS : 82.16 (+0.13%)
Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 24.39% and 1.54%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 82.16 (+0.13%)
Exact Sciences: 3Q Earnings Snapshot

MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $40.5 million in its third quarter.

EXAS : 82.16 (+0.13%)
Exact Sciences Presents New Stool-Based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

(NASDAQ: EXAS) - Promising research from Exact Sciences Corp. and Mayo Clinic shows new methylation and protein markers detect colorectal cancer and advanced adenomas with high accuracy. Findings from...

EXAS : 82.16 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

See More Share

Trade EXAS with:

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Key Turning Points

2nd Resistance Point 83.20
1st Resistance Point 82.68
Last Price 82.16
1st Support Level 81.57
2nd Support Level 80.98

See More

52-Week High 123.99
Fibonacci 61.8% 96.89
Fibonacci 50% 88.53
Last Price 82.16
Fibonacci 38.2% 80.16
52-Week Low 53.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar